Correction to: Survival in advanced GIST has improved over time and correlates with increased access to post-imatinib tyrosine kinase inhibitors: results from Life Raft Group Registry
- PMID: 31080577
- PMCID: PMC6503372
- DOI: 10.1186/s13569-019-0117-2
Correction to: Survival in advanced GIST has improved over time and correlates with increased access to post-imatinib tyrosine kinase inhibitors: results from Life Raft Group Registry
Abstract
[This corrects the article DOI: 10.1186/s13569-019-0114-5.].
Erratum for
-
Survival in advanced GIST has improved over time and correlates with increased access to post-imatinib tyrosine kinase inhibitors: results from Life Raft Group Registry.Clin Sarcoma Res. 2019 Apr 2;9:4. doi: 10.1186/s13569-019-0114-5. eCollection 2019. Clin Sarcoma Res. 2019. PMID: 30984366 Free PMC article.
References
-
- Call JW, Wang Y, Montoya D, Scherzer NJ, Heinrich MC. Survival in advanced GIST has improved over time and correlates with increased access to post-imatinib tyrosine kinase inhibitors: results from Life Raft Group Registry. Clin Sarcoma Res. 2019;9:4. doi: 10.1186/s13569-019-0114-5. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
